Male BRCA-associated tumors were predominantly stage II or III disease with a higher frequency of BRCA2 mutations and were more commonly found in cutaneous melanoma and carcinoma of the lung, bladder, and stomach compared to those in non-BRCAm carriers. The gene discussed is BRCA2; the disease is cutaneous melanoma.